TY - JOUR
AU - 
TI - Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint
JF - Molecular Cancer Therapeutics
DO - 10.1158/1535-7163.mct-06-0371
DA - 2007-01-01
UR - https://www.deepdyve.com/lp/unpaywall/cell-cycle-phenotype-based-optimization-of-g2-abrogating-peptides-d0yODaBv6S
DP - DeepDyve
ER -